Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Otsuka America Pharmaceutical, Inc.

New Study Finds Family Caregivers Would Earn Six Figures If Paid A Salary
From Otsuka America Pharmaceutical, Inc.
Via Business Wire
Meharry School of Global Health Releases Landmark Report Showing Mental Health Inequities in the U.S. Could Cost an Estimated $14 Trillion by 2040
From Otsuka America Pharmaceutical, Inc.
Via Business Wire
Otsuka Becomes Lead Founding Sponsor of PBS and WETA’s New Caregiving Documentary, Executive Produced by Bradley Cooper
From Otsuka America Pharmaceutical, Inc.
Via Business Wire
FDA Approves Otsuka and Lundbeck’s ABILIFY ASIMTUFII® (aripiprazole), the First Once-Every-Two-Months Long-acting Injectable (LAI) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults
From Otsuka America Pharmaceutical, Inc.
Via Business Wire
Otsuka Pharmaceutical & Lundbeck Present Positive Data From Multiple Phase 3 Studies Showing Brexpiprazole Significantly Improved Symptoms of Agitation in Patients With Alzheimer’s Dementia at the 2022 Clinical Trials for Alzheimer’s Disease Congress
From Otsuka America Pharmaceutical, Inc.
Via Business Wire
Otsuka and Lundbeck Announce U.S. FDA Acceptance of New Drug Application for Aripiprazole 2-month, Ready-to-Use, Long-acting Injectable to Treat Schizophrenia and Bipolar I Disorder in Adults
From Otsuka America Pharmaceutical, Inc.
Via Business Wire
4th Annual Mental Health Policy Forum Convenes National Policymakers and Advocates on Capitol Hill
From Otsuka America Pharmaceutical, Inc.
Via Business Wire
Otsuka and Lundbeck Announce FDA Approval of Supplemental New Drug Application for REXULTI® (brexpiprazole) to Treat Schizophrenia in Pediatric Patients Ages 13-17
From Otsuka America Pharmaceutical, Inc.
Via Business Wire
Otsuka Responds to the Office of Inspector General’s Favorable Opinion Regarding its Hospital Free Trial Program of Long-Acting Injectable for Inpatient Schizophrenia Treatment
From Otsuka America Pharmaceutical, Inc.
Via Business Wire
Otsuka Hosts Dr. Nina Vasan, Governor Charlie Baker, and Representative Jamie Raskin at Third Annual Advancing Mental Health Policy: BetterTogether Forum
From Otsuka America Pharmaceutical, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.